Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making.
about
Chinese herbal medicine for oesophageal cancerAndrogens for the anaemia of chronic kidney disease in adultsChinese herbal medicines for esophageal cancerImmunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplastyAndrogens for the anaemia of chronic kidney disease in adultsChinese herbal medicine alone or combined with vitamins for gastric precancerous lesionsEffects of immunosuppressants after penetrating keratoplasty: meta-analysis of randomized controlled trials.How should we manage information needs, family anxiety, depression, and breathlessness for those affected by advanced disease: development of a Clinical Decision Support Tool using a Delphi design.Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACTThe Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative.Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes.Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial.Quality of Life in CAM and Non-CAM Users among Breast Cancer Patients during Chemotherapy in MalaysiaQuality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials.Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumoursQuality of life and adjuvant systemic therapy for early-stage breast cancer.Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 StudyImproving patient-centered medical-surgical nursing practice with quality-of-life assessment.Baseline quality of life factors predict long term survival after elective resection for colorectal cancer.Reporting on quality of life in randomised controlled trials in gastrointestinal surgeryQuality of life research: types of publication output over time for cancer patients, a systematic review.Health-related quality-of-life assessment in GI cancer randomized trials: improving the impact on clinical practice.Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG.Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes.Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers.Cautionary tales in the clinical interpretation of trials assessing therapy-induced changes in health status.Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer.Patient-reported outcomes in bariatric surgery: a systematic review of standards of reporting.Health-related quality of life in patients with brain tumors: limitations and additional outcome measures.Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.Quality of Life in Community-Dwelling Chinese American Patients with Cancer Pain.Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization fThe CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice.Methodological issues in designing and reporting health-related quality of life in cancer clinical trials: the challenge of brain cancer studies.Disregarding clinical trial-based patient-reported outcomes is unwarranted: Five advances to substantiate the scientific stringency of quality-of-life measurement.Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review.Quality of life questionnaires in otorhinolaryngology: a systematic overview.The longitudinal relationship between quality of life and survival in advanced stage cancer.Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy.
P2860
Q24186392-013986E9-9D5C-4B9A-A27F-5B68A7552F9BQ24193138-1EB9814A-C8F7-49C1-9DC0-9DCC9D502FBCQ24240294-52405679-62B5-4016-9821-B02A0E7AD6F1Q24240566-8791AF1F-9E5F-4C5C-AB46-BC6380B9CEA7Q24242990-CA643267-C0CB-42C9-9461-F308D33CEDF2Q24243598-F0B2F3AA-A352-4F01-BBB7-D6959061E6EBQ30467905-73C8FAAF-1ACB-4028-AC35-EE7E36AF3081Q30668504-B20D9CFD-215D-4472-8F99-C6DAAF49448DQ30671538-BDC83912-291C-4039-B089-D42C48D03242Q31034367-D1F754B1-5735-4694-9C44-4BF1FA20E157Q34293847-13C8AA6E-76D8-41BF-AC14-FFEE90B37A29Q35111780-A962546B-E384-4754-A80A-EAB79310904CQ35771173-F8DC3B67-B70E-44FE-A3BF-5DE900E3483CQ35801547-723E32D0-D8E4-4974-AAF7-C513821C1F36Q36584771-DF730B5F-BFF4-4D95-9741-79B8765E7E19Q36594133-15B0CED9-68B0-4F0F-B6B1-6281A4F6A8B5Q37008863-F91B456A-EF3D-45D9-9E09-D226C5BE714FQ37038467-A0585C06-FCEF-4319-8259-262788F6B883Q37067944-199A6886-7755-44B5-BD40-405AC6E4D590Q37392987-E90CC6FA-94B6-4C89-BB78-E40F740B957BQ37614291-642B96B0-4392-4525-AE3A-EFBAFCFB641BQ37615519-80C67BC0-979A-4BCE-B94A-2F9307B59850Q37639326-B20D5A7F-565E-4EC4-BCD9-41184AC3C9E2Q37729195-AF31C061-1D56-4912-8262-DFD9E9F80D6AQ37810109-72D0B558-3A60-4159-A842-76789DD30AD9Q37812571-14F9590C-EF26-4829-BD96-D08A786D590CQ37864715-AF601959-230C-4C19-B22E-CB56F7A3A0A6Q38053978-524D3B98-A155-4916-AD2D-3FF2DB0222C7Q38103621-D2B54DA1-A8B9-430D-A74D-BBA544EB7714Q38105945-7F5E0012-88E4-4AC2-8A0E-EFD0665FF7BFQ38674157-9AF88F13-6D2B-4AD1-A4DB-62D6D5486DA0Q38893045-05B4A801-8A7D-423D-9AA8-8129251E260FQ41701973-313FAF90-3E83-4B3E-B8DD-07E5122DC4A7Q42862858-28CE9704-4E74-47AD-97FB-22BEC87DE4FAQ44669659-719195E5-40F0-4A86-BC85-50B6E9BF9115Q45973699-D41F0644-02E6-4BB4-8CB1-F1B8F6B0630EQ47555206-00E4253D-CEF6-4568-93B2-46BB5C055DC2Q47908896-EF36D9AF-AE96-4CB8-9ABA-8D1883150583Q48038841-8295E132-E774-4315-8615-E9E680D913A9Q48061245-6F7F6760-2447-4E61-B949-454A35474B18
P2860
Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Has the quality of health-rela ...... with clinical decision making.
@en
type
label
Has the quality of health-rela ...... with clinical decision making.
@en
prefLabel
Has the quality of health-rela ...... with clinical decision making.
@en
P2093
P356
P1433
P1476
Has the quality of health-rela ...... with clinical decision making.
@en
P2093
P304
P356
10.1093/ANNONC/MDL494
P577
2007-01-27T00:00:00Z